183 related articles for article (PubMed ID: 32793906)
1. Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity.
Liu H; Wu NC; Yuan M; Bangaru S; Torres JL; Caniels TG; van Schooten J; Zhu X; Lee CD; Brouwer PJM; van Gils MJ; Sanders RW; Ward AB; Wilson IA
bioRxiv; 2020 Aug; ():. PubMed ID: 32793906
[TBL] [Abstract][Full Text] [Related]
2. Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity.
Liu H; Wu NC; Yuan M; Bangaru S; Torres JL; Caniels TG; van Schooten J; Zhu X; Lee CD; Brouwer PJM; van Gils MJ; Sanders RW; Ward AB; Wilson IA
Immunity; 2020 Dec; 53(6):1272-1280.e5. PubMed ID: 33242394
[TBL] [Abstract][Full Text] [Related]
3. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
Zhan W; Tian X; Zhang X; Xing S; Song W; Liu Q; Hao A; Hu Y; Zhang M; Ying T; Chen Z; Lan F; Sun L
J Virol; 2022 Aug; 96(16):e0048022. PubMed ID: 35924918
[TBL] [Abstract][Full Text] [Related]
4. Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.
Jette CA; Cohen AA; Gnanapragasam PNP; Muecksch F; Lee YE; Huey-Tubman KE; Schmidt F; Hatziioannou T; Bieniasz PD; Nussenzweig MC; West AP; Keeffe JR; Bjorkman PJ; Barnes CO
Cell Rep; 2021 Sep; 36(13):109760. PubMed ID: 34534459
[TBL] [Abstract][Full Text] [Related]
5. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
Jensen JL; Sankhala RS; Dussupt V; Bai H; Hajduczki A; Lal KG; Chang WC; Martinez EJ; Peterson CE; Golub ES; Rees PA; Mendez-Rivera L; Zemil M; Kavusak E; Mayer SV; Wieczorek L; Kannan S; Doranz BJ; Davidson E; Yang ES; Zhang Y; Chen M; Choe M; Wang L; Gromowski GD; Koup RA; Michael NL; Polonis VR; Rolland M; Modjarrad K; Krebs SJ; Joyce MG
J Virol; 2023 Jul; 97(7):e0159622. PubMed ID: 37395646
[TBL] [Abstract][Full Text] [Related]
7. An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope.
Liu Z; Xu W; Chen Z; Fu W; Zhan W; Gao Y; Zhou J; Zhou Y; Wu J; Wang Q; Zhang X; Hao A; Wu W; Zhang Q; Li Y; Fan K; Chen R; Jiang Q; Mayer CT; Schoofs T; Xie Y; Jiang S; Wen Y; Yuan Z; Wang K; Lu L; Sun L; Wang Q
Protein Cell; 2022 Sep; 13(9):655-675. PubMed ID: 34554412
[TBL] [Abstract][Full Text] [Related]
8. Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibody.
Li T; Cai H; Zhao Y; Li Y; Lai Y; Yao H; Liu LD; Sun Z; van Vlissingen MF; Kuiken T; GeurtsvanKessel CH; Zhang N; Zhou B; Lu L; Gong Y; Qin W; Mondal M; Duan B; Xu S; Richard AS; Raoul H; Chen J; Xu C; Wu L; Zhou H; Huang Z; Zhang X; Li J; Wang Y; Bi Y; Rockx B; Chen J; Meng FL; Lavillette D; Li D
EMBO Mol Med; 2021 Dec; 13(12):e14544. PubMed ID: 34672091
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Antibody Effectiveness Is Influenced by Non-Epitope Mutation/Binding-Induced Denaturation of the Epitope 3D Architecture.
Malisheni MM; Bates M; Rizvanov AA; MacAry PA
Pathogens; 2022 Nov; 11(12):. PubMed ID: 36558771
[TBL] [Abstract][Full Text] [Related]
10. Epitope Profiling Reveals the Critical Antigenic Determinants in SARS-CoV-2 RBD-Based Antigen.
Jiang M; Zhang G; Liu H; Ding P; Liu Y; Tian Y; Wang Y; Wang A
Front Immunol; 2021; 12():707977. PubMed ID: 34621266
[TBL] [Abstract][Full Text] [Related]
11. Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies.
Li R; Mor M; Ma B; Clark AE; Alter J; Werbner M; Lee JC; Leibel SL; Carlin AF; Dessau M; Gal-Tanamy M; Croker BA; Xiang Y; Freund NT
Commun Biol; 2022 Aug; 5(1):789. PubMed ID: 35931732
[TBL] [Abstract][Full Text] [Related]
12. Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV.
Jiang W; Wang J; Jiao S; Gu C; Xu W; Chen B; Wang R; Chen H; Xie Y; Wang A; Li G; Zeng D; Zhang J; Zhang M; Wang S; Wang M; Gui X
MAbs; 2021; 13(1):1953683. PubMed ID: 34313527
[TBL] [Abstract][Full Text] [Related]
13. Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2.
Lai YC; Cheng YW; Chao CH; Chang YY; Chen CD; Tsai WJ; Wang S; Lin YS; Chang CP; Chuang WJ; Chen LY; Wang YR; Chang SY; Huang W; Wang JR; Tseng CK; Lin CK; Chuang YC; Yeh TM
Front Immunol; 2022; 13():868724. PubMed ID: 35603169
[TBL] [Abstract][Full Text] [Related]
14. 35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitope.
Wang X; Chen X; Tan J; Yue S; Zhou R; Xu Y; Lin Y; Yang Y; Zhou Y; Deng K; Chen Z; Ye L; Zhu Y
Cell Host Microbe; 2022 Jun; 30(6):887-895.e4. PubMed ID: 35436443
[TBL] [Abstract][Full Text] [Related]
15. Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody.
Prabakaran P; Gan J; Feng Y; Zhu Z; Choudhry V; Xiao X; Ji X; Dimitrov DS
J Biol Chem; 2006 Jun; 281(23):15829-36. PubMed ID: 16597622
[TBL] [Abstract][Full Text] [Related]
16. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.
Tian X; Li C; Huang A; Xia S; Lu S; Shi Z; Lu L; Jiang S; Yang Z; Wu Y; Ying T
Emerg Microbes Infect; 2020; 9(1):382-385. PubMed ID: 32065055
[TBL] [Abstract][Full Text] [Related]
17. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.
Sui J; Deming M; Rockx B; Liddington RC; Zhu QK; Baric RS; Marasco WA
J Virol; 2014 Dec; 88(23):13769-80. PubMed ID: 25231316
[TBL] [Abstract][Full Text] [Related]
18. Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2.
Sun X; Yi C; Zhu Y; Ding L; Xia S; Chen X; Liu M; Gu C; Lu X; Fu Y; Chen S; Zhang T; Zhang Y; Yang Z; Ma L; Gu W; Hu G; Du S; Yan R; Fu W; Yuan S; Qiu C; Zhao C; Zhang X; He Y; Qu A; Zhou X; Li X; Wong G; Deng Q; Zhou Q; Lu H; Ling Z; Ding J; Lu L; Xu J; Xie Y; Sun B
Nat Microbiol; 2022 Jul; 7(7):1063-1074. PubMed ID: 35773398
[TBL] [Abstract][Full Text] [Related]
19. Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.
Jette CA; Cohen AA; Gnanapragasam PNP; Muecksch F; Lee YE; Huey-Tubman KE; Schmidt F; Hatziioannou T; Bieniasz PD; Nussenzweig MC; West AP; Keeffe JR; Bjorkman PJ; Barnes CO
bioRxiv; 2021 Apr; ():. PubMed ID: 33948592
[TBL] [Abstract][Full Text] [Related]
20. The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies.
Zhang S; Gao C; Das T; Luo S; Tang H; Yao X; Cho CY; Lv J; Maravillas K; Jones V; Chen X; Huang R
J Immunol Methods; 2022 Apr; 503():113244. PubMed ID: 35218866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
